Position in PFE
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$564,387
-$66,963 QoQ
Shares Held
23,438
+4.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,673
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Roundview Capital LLC holds $44,317,424 across 9 Drug Manufacturers - General names. PFE ranks #6 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
72,050 | $18,298,538 | |
| 2 | LLY |
ELI LILLY & Co
|
8,070 | $9,679,400 | |
| 3 | ABBV |
AbbVie Inc.
|
30,467 | $7,666,715 | |
| 4 | MRK |
Merck & Co., Inc.
|
42,411 | $5,449,813 | |
| 5 | NVO |
Novo Nordisk A S
|
32,028 | $1,535,422 | |
| 6 | PFE |
Pfizer Inc
This page
|
23,438 | $564,387 | |
| 7 | NVS |
Novartis AG
|
2,707 | $424,241 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,618 | $381,329 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $564,387 | 23,438 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $631,350 | 22,484 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $662,663 | 26,613 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $628,413 | 24,663 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $603,285 | 24,888 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $741,676 | 29,269 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,053,081 | 39,694 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,183,993 | 40,912 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,195,893 | 42,741 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,300,309 | 46,858 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,457,349 | 50,620 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,029,904 | 61,197 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,329,583 | 63,511 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,570,848 | 63,011 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $3,401,003 | 66,374 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,798,802 | 63,958 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,362,965 | 64,142 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,351,072 | 64,730 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $3,765,028 | 63,760 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,867,863 | 66,679 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,116,676 | 54,052 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,257,237 | 62,303 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,392,281 | 64,990 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $2,453,465 | 66,852 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $2,190,869 | 66,999 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,361,337 | 72,345 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||